{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:02Z","timestamp":1793831222146,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T00:00:00Z","timestamp":1576540800000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/objectives<\/jats:title>\n                    <jats:p>Assessing the clinical relevance of non-tuberculous mycobacteria (NTM) isolated from respiratory samples can be challenging. The epidemiology and pathogenicity of NTM species vary geographically. We aimed to outline the clinical relevance and associated radiological patterns of NTM species isolated in Belgium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We performed a retrospective multicentre analysis of all patients identified from the laboratory database with\n                      <jats:underline>&gt;<\/jats:underline>\n                      \u20091 respiratory sample growing NTM from January 2010 through December 2017. We collected clinical, radiological and microbiological data through medical record review and assessed clinical relevance according to ATS\/IDSA criteria for NTM pulmonary disease (NTM-PD).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 384 unique patients, 60% were male, 56% had a smoking history and 61% had pre-existing lung disease.\n                      <jats:italic>Mycobacterium avium<\/jats:italic>\n                      complex (MAC),\n                      <jats:italic>M. gordonae<\/jats:italic>\n                      and\n                      <jats:italic>M. xenopi<\/jats:italic>\n                      were the most frequently isolated species: 53, 15 and 8% respectively. 43% of patients met ATS\/IDSA criteria, of whom 28% presented with fibrocavitary disease. Weight loss, fever, nodular bronchiectatic and fibrocavitary lesions on chest CT, and a positive acid-fast bacilli (AFB) stain were significantly associated with NTM-PD. The species with the highest pathogenic potential were\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      (11\/12),\n                      <jats:italic>M. malmoense<\/jats:italic>\n                      (6\/7) and\n                      <jats:italic>M. intracellulare<\/jats:italic>\n                      (41\/64).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In our study, MAC was the most commonly isolated NTM species, but\n                      <jats:italic>M. abscessus<\/jats:italic>\n                      and\n                      <jats:italic>M. malmoense<\/jats:italic>\n                      showed the highest probability of being clinically relevant. Clinical relevance varied not only by species but also by radiological findings on chest CT and AFB staining. Clinicians should consider these elements in their treatment decision making. Prospective data including clinical outcome are needed to provide more robust evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-019-4683-y","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T14:03:02Z","timestamp":1576591382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-9420","authenticated-orcid":false,"given":"Yannick","family":"Vande Weygaerde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Cardinaels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bomans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeyang","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerina","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Van Braeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Lorent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,17]]},"reference":[{"key":"4683_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccm.2014.10.003","volume":"36","author":"JO Falkinham","year":"2015","unstructured":"Falkinham JO. Environmental sources of nontuberculous mycobacteria. Clin Chest Med. 2015;36:35\u201341.","journal-title":"Clin Chest Med"},{"key":"4683_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.01614-18","volume":"9","author":"MJ Gebert","year":"2018","unstructured":"Gebert MJ, Delgado-Baquerizo M, Oliverio AM, Webster TM, Nichols LM, Honda JR, et al. Ecological analyses of mycobacteria in showerhead biofilms and their relevance to human health. MBio. 2018;9:1\u201315.","journal-title":"MBio"},{"key":"4683_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fmicb.2018.00067","volume":"9","author":"RS Gupta","year":"2018","unstructured":"Gupta RS, Lo B, Son J. Phylogenomics and comparative genomic studies robustly support division of the genus Mycobacterium into an emended genus Mycobacterium and four novel genera. Front Microbiol. 2018;9:67.","journal-title":"Front Microbiol"},{"key":"4683_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 2","key":"4683_CR5","doi-asserted-by":"publisher","first-page":"ii1 LP","DOI":"10.1136\/thoraxjnl-2017-210927","volume":"72","author":"CS Haworth","year":"2017","unstructured":"Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1 LP\u2013ii64.","journal-title":"Thorax"},{"key":"4683_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1164\/rccm.200905-0778OC","volume":"181","author":"C Andr\u00e9jak","year":"2010","unstructured":"Andr\u00e9jak C, Thomsen V\u00d8, Johansen IS, Riis A, Benfield TL, Duhaut P, et al. Nontuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med. 2010;181:514\u201321.","journal-title":"Am J Respir Crit Care Med"},{"key":"4683_CR7","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","volume":"71","author":"RA Floto","year":"2016","unstructured":"Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann JL, Nick JA, et al. US Cystic Fibrosis Foundation and European cystic fibrosis society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016;71:i1\u201322.","journal-title":"Thorax"},{"key":"4683_CR8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1183\/13993003.00033-2016","volume":"48","author":"TK Marras","year":"2016","unstructured":"Marras TK, Campitelli MA, Kwong JC, Lu H, Brode SK, Marchand-Austin A, et al. Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease. Eur Respir J. 2016;48:928\u201331.","journal-title":"Eur Respir J"},{"key":"4683_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccm.2014.11.002","volume":"36","author":"E Henkle","year":"2015","unstructured":"Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med. 2015;36:91\u20139.","journal-title":"Clin Chest Med"},{"key":"4683_CR10","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1513\/AnnalsATS.201709-727OC","volume":"15","author":"J Adjemian","year":"2018","unstructured":"Adjemian J, Olivier KN, Prevots DR. Epidemiology of pulmonary Nontuberculous mycobacterial sputum positivity in patients with cystic fibrosis in the United States, 2010-2014. Ann Am Thorac Soc. 2018;15:817\u201326.","journal-title":"Ann Am Thorac Soc"},{"key":"4683_CR11","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3201\/eid2206.151642","volume":"22","author":"FC Ringshausen","year":"2016","unstructured":"Ringshausen FC, Wagner D, de Roux A, Diel R, Hohmann D, Hickstein L, et al. Prevalence of Nontuberculous mycobacterial pulmonary disease, Germany, 2009\u20132014. Emerg Infect Dis. 2016;22:1102\u20135.","journal-title":"Emerg Infect Dis"},{"key":"4683_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","volume":"36","author":"DR Prevots","year":"2015","unstructured":"Prevots DR, Marras TK. Epidemiology of human pulmonary infection with Nontuberculous mycobacteria. Clin Chest Med. 2015;36:13\u201334.","journal-title":"Clin Chest Med"},{"key":"4683_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3201\/eid1911.130737","volume":"19","author":"TK Marras","year":"2013","unstructured":"Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis. 2013;19:1889\u201391.","journal-title":"Emerg Infect Dis"},{"key":"4683_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3201\/eid2303.161827","volume":"23","author":"J Adjemian","year":"2017","unstructured":"Adjemian J, Frankland TB, Daida YG, Honda JR, Olivier KN, Zelazny A, et al. Epidemiology of Nontuberculous mycobacterial lung disease and tuberculosis, Hawaii, USA. Emerg Infect Dis. 2017;23:439\u201347.","journal-title":"Emerg Infect Dis"},{"key":"4683_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1055\/s-0038-1660864","volume":"39","author":"S Zweijpfenning","year":"2018","unstructured":"Zweijpfenning S, Ingen J, Hoefsloot W. Geographic distribution of Nontuberculous mycobacteria isolated from clinical specimens: a systematic review. Semin Respir Crit Care Med. 2018;39:336\u201342.","journal-title":"Semin Respir Crit Care Med"},{"key":"4683_CR16","first-page":"1176","volume":"14","author":"J van Ingen","year":"2010","unstructured":"van Ingen J, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, van Soolingen D. The changing pattern of clinical Mycobacterium avium isolation in the Netherlands. Int J Tuberc Lung Dis. 2010;14:1176\u201380.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4683_CR17","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.2807\/1560-7917.ES.2019.24.11.1800205","volume":"24","author":"K Soetaert","year":"2019","unstructured":"Soetaert K, Subissi L, Ceyssens P-J, Vanfleteren B, Chantrenne M, Asikainen T, et al. Strong increase of true and false positive mycobacterial cultures sent to the National Reference Centre in Belgium, 2007 to 2016. Eurosurveillance. 2019;24:2015\u20139.","journal-title":"Eurosurveillance"},{"key":"4683_CR18","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1183\/09031936.00149212","volume":"42","author":"W Hoefsloot","year":"2013","unstructured":"Hoefsloot W, Van Ingen J, Andrejak C, \u00c4ngeby K, Bauriaud R, Bemer P, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42:1604\u201313.","journal-title":"Eur Respir J"},{"key":"4683_CR19","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3201\/eid1610.091201","volume":"16","author":"RM Thomson","year":"2010","unstructured":"Thomson RM. NTM working group at Queensland TB control Centre and Queensland mycobacterial reference laboratory. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis. 2010;16:1576\u201383.","journal-title":"Emerg Infect Dis"},{"key":"4683_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4046\/trd.2013.75.5.199","volume":"75","author":"W-J Koh","year":"2013","unstructured":"Koh W-J, Chang B, Jeong B-H, Jeon K, Kim S-Y, Lee NY, et al. Increasing recovery of Nontuberculous mycobacteria from respiratory specimens over a 10-year period in a tertiary referral Hospital in South Korea. Tuberc Respir Dis (Seoul). 2013;75:199\u2013204.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"4683_CR21","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3346\/jkms.2017.32.8.1263","volume":"32","author":"N Kim","year":"2017","unstructured":"Kim N, Yi J, Chang CL. Recovery rates of non-Tuberculous mycobacteria from clinical specimens are increasing in Korean tertiary-care hospitals. J Korean Med Sci. 2017;32:1263\u20137.","journal-title":"J Korean Med Sci"},{"key":"4683_CR22","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1099\/jmm.0.000359","volume":"65","author":"K Soetaert","year":"2016","unstructured":"Soetaert K, Vluggen C, Andr\u00e9 E, Vanhoof R, Vanfleteren B, Mathys V. Frequency of Mycobacterium chimaera among Belgian patients, 2015. J Med Microbiol. 2016;65:1307\u201310.","journal-title":"J Med Microbiol"},{"key":"4683_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/thx.2008.110957","volume":"64","author":"J Van Ingen","year":"2009","unstructured":"Van Ingen J, Bendien SA, De Lange WCM, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax. 2009;64:502\u20136.","journal-title":"Thorax"},{"key":"4683_CR24","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1038\/s41598-017-06931-4","volume":"7","author":"TS Hermansen","year":"2017","unstructured":"Hermansen TS, Ravn P, Svensson E, Lillebaek T. Nontuberculous mycobacteria in Denmark , incidence and clinical importance during the last quarter- century. Sci Rep. 2017;7:6696.","journal-title":"Sci Rep"},{"key":"4683_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1521-3","volume":"16","author":"NM Shah","year":"2016","unstructured":"Shah NM, Davidson JA, Anderson LF, Lalor MK, Kim J, Thomas HL, et al. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012. BMC Infect Dis. 2016;16:1\u20136.","journal-title":"BMC Infect Dis"},{"key":"4683_CR26","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","volume":"185","author":"J Adjemian","year":"2012","unstructured":"Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. medicare beneficiaries. Am J Respir Crit Care Med. 2012;185:881\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"4683_CR27","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/s41598-018-37350-8","volume":"9","author":"HF Schiff","year":"2019","unstructured":"Schiff HF, Jones S, Achaiah A, Pereira A, Stait G, Green B. Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital. Sci Rep. 2019;9:1730.","journal-title":"Sci Rep"},{"key":"4683_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1378\/chest.129.2.341","volume":"129","author":"W-J Koh","year":"2006","unstructured":"Koh W-J, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest. 2006;129:341\u20138.","journal-title":"Chest."},{"key":"4683_CR29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","volume":"151","author":"TR Aksamit","year":"2017","unstructured":"Aksamit TR, O\u2019Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels MLA, et al. Adult patients with bronchiectasis. Chest. 2017;151:982\u201392.","journal-title":"Chest"},{"key":"4683_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","volume":"185","author":"M Hayashi","year":"2012","unstructured":"Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;185:575\u201383.","journal-title":"Am J Respir Crit Care Med"},{"key":"4683_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/thoraxjnl-2012-201772","volume":"68","author":"C Andr\u00e9jak","year":"2013","unstructured":"Andr\u00e9jak C, Nielsen R, Thomsen V\u00d8, Duhaut P, S\u00f8rensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68:256\u201362.","journal-title":"Thorax."},{"key":"4683_CR32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.5588\/ijtld.11.0148","volume":"16","author":"Y Ito","year":"2012","unstructured":"Ito Y, Hirai T, Maekawa K, Fujita K, Imai S, Tatsumi S, et al. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis. 2012;16:408\u201314.","journal-title":"Int J Tuberc Lung Dis."},{"issue":"3","key":"4683_CR33","doi-asserted-by":"publisher","first-page":"1600537","DOI":"10.1183\/13993003.00537-2016","volume":"49","author":"Ji An Hwang","year":"2017","unstructured":"Hwang JA, Kim S, Jo KW, Shim TS. Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course. Eur Respir J. 2017;49(3).","journal-title":"European Respiratory Journal"},{"key":"4683_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1183\/09031936.06.00139005","volume":"28","author":"H Kunst","year":"2006","unstructured":"Kunst H, Wickremasinghe M, Wells A, Wilson R. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis. Eur Respir J. 2006;28:352\u20137.","journal-title":"Eur Respir J"},{"key":"4683_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12879-018-3559-x","volume":"18","author":"J Provoost","year":"2018","unstructured":"Provoost J, Valour F, Gamondes D, Roux S, Freymond N, Perrot E, et al. A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity. BMC Infect Dis. 2018;18:659.","journal-title":"BMC Infect Dis"},{"key":"4683_CR36","doi-asserted-by":"publisher","first-page":"1900117","DOI":"10.1183\/13993003.00117-2019","volume":"54","author":"K Geurts","year":"2019","unstructured":"Geurts K, Zweijpfenning SMH, Pennings LJ, Schildkraut JA, Boeree MJ, Magis-Escurra C, et al. Nontuberculous mycobacterial pulmonary disease and Aspergillus co-infection: Bonnie and Clyde? Eur Respir J. 2019;54:1900117.","journal-title":"Eur Respir J"},{"key":"4683_CR37","first-page":"1186","volume":"8","author":"N Mart\u00edn-Casabona","year":"2004","unstructured":"Mart\u00edn-Casabona N, Bahrmand AR, Bennedsen J, \u00d8stergaard Thomsen V, Curcio M, Fauville-Dufaux M, et al. Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis. 2004;8:1186\u201393.","journal-title":"Int J Tuberc Lung Dis"},{"key":"4683_CR38","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1164\/rccm.201501-0067OC","volume":"191","author":"DP Boyle","year":"2015","unstructured":"Boyle DP, Zembower TR, Reddy S, Qi C. Comparison of clinical features, virulence, and relapse among Mycobacterium avium complex species. Am J Respir Crit Care Med. 2015;191:1310\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"4683_CR39","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.rmed.2012.06.023","volume":"106","author":"A Matveychuk","year":"2012","unstructured":"Matveychuk A, Fuks L, Priess R, Hahim I, Shitrit D. Clinical and radiological features of Mycobacterium kansasii and other NTM infections. Respir Med. 2012;106:1472\u20137.","journal-title":"Respir Med"},{"key":"4683_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1148\/radiol.2351040371","volume":"235","author":"W-J Koh","year":"2005","unstructured":"Koh W-J, Lee KS, Kwon OJ, Jeong YJ, Kwak S-H, Kim TS. Bilateral bronchiectasis and bronchiolitis at thin-section CT: diagnostic implications in nontuberculous mycobacterial pulmonary infection. Radiology. 2005;235:282\u20138.","journal-title":"Radiology."},{"key":"4683_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1440-1843.2012.02277.x","volume":"18","author":"TK Marras","year":"2013","unstructured":"Marras TK, Wagnetz U, Jamieson FB, Patsios DA. Chest computed tomography predicts microbiological burden and symptoms in pulmonary Mycobacterium xenopi. Respirology. 2013;18:92\u2013101.","journal-title":"Respirology."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4683-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4683-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T19:08:54Z","timestamp":1608059334000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4683-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4683"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4683-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13986\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13986\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"23 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"<i>University Hospitals Leuven<\/i>Central Ethics Committee: Ethics Committee Research UZ\/ KU Leuven, BelgiumApproval code: S61188<i>Ghent University Hospital<\/i>Ethics Committee of the Ghent University Hospital, BelgiumApproval code: EC\/2018\/0356<i>ZNA Stuivenberg<\/i>Commissie voor Medische Ethiek ZNA \u2013 Institutional Review Board ZNA\/OCMW Antwerpen, Belgium:Approval code: 5064<i>Statement on the need for informed consent:<\/i>The need for informed consent was waived because of the exclusively retrospective nature of the study. Non-tuberculous mycobacteria are frequently isolated from respiratory samples as they are ubiquitous in the environment and often not related to pathology. Some people might have been unaware of insignificant NTM positive isolates and asking for consent might have caused unnecessary distress and unease. Some patients included, had already died, mostly of other causes and asking consent to the next of kin might have caused additional, unnecessary distress and sorrow. Furthermore, data were analysed anonymously.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1061"}}